Endo Pharmaceuticals Holdings, Inc.
Pain-management company reports positive second-quarter results
Published in FDA Law Weekly, August 12th, 2004
Net sales for the 2nd quarter were $144.0 million, compared to $152.0 million in the 2nd quarter of 2003. Net income for the 3 months ended June 30, 2004 was $31.5 million compared to $45.2 million in the comparable 2003 period. Adjusted net income for the 3 months ended June 30, 2004 was $37.8 million compared with $46.1 million in the same period in 2003.
Diluted earnings per share for the 3 months ended June 30, 2004 were $0.24 compared with $0.34 in 2003. Adjusted...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
Source: FDA Law Weekly (2004-08-12)
More Articles from FDA Law Weekly
- Titan, Pharmaceuticals, Inc
Spheramine for Parkinson receives FDA fast track designation - American Pharmaceutical Partners, Inc.
Tobramycin powder launched, marking company's first NDA approval - Atrix Laboratories, Inc.
Tentative approval granted from FDA for Mometasone cream - Barr Pharmaceuticals, Inc.
Response submitted to FDA in support of OTC status for emergency contraceptive - BioMimetic Pharmaceuticals, Inc.
Approvable recommendation issued from FDA panel for GEM 21S - Bioterrorism
Report shows bioterrorism preparedness progress lacking in rural areas - More from this issue of FDA Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
